Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
NEULANDLAB
NEULANDLAB

Neuland Laboratories Ltd.

NSE: NEULANDLAB
BSE: 524558
Sector: Healthcare
Industry: Pharmaceuticals
18,889.00-11.0 (-0.06%)
8 Jul, 12:00 AM

Stock Scores

Quality Score

94.2 / 100

Value Score

9.8 / 100

Price Momentum Score

95.5 / 100

QVM Score

82.2 / 100

Key Metrics

Market Cap
24234.60
P/E (TTM)
66.58
P/B
12.93
P/S (TTM)
11.98
EV/EBITDA
42.08
CAPE (5Y)
105.23
ROE (TTM)
21.42
ROCE (TTM)
25.03
ROA (TTM)
14.25
Avg 3Y ROE
22.10
Earnings 3Y CAGR
30.57
Sales 3Y CAGR
19.31
Sales 5Y CAGR
16.64
Debt/Equity
0.16
Consensus TP
20712.50
Strong Buy %
50.00
Promoter Holding
32.63
Pledged %
2.29

Share Price

Track Neuland Laboratories Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 0.55 %
Low
18,400.0
High
19,397.0
1 Month returns: 11.35 %
Low
16,560.0
High
19,397.0
1 Year returns: 61.36 %
Low
11,500.0
High
19,748.4
3 Year CAGR: 82.16 %
Low
2,870.1
High
19,748.4
5 Year CAGR: 53.33 %
Low
967.0
High
19,748.4
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Neuland Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Neuland Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Neuland Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Neuland Laboratories Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Neuland Laboratories Ltd.?
The current share price of Neuland Laboratories Ltd. is ₹ 18,889.00 as of 8 Jul 2026.
What is the market capitalisation of Neuland Laboratories Ltd.?
The market capitalisation of Neuland Laboratories Ltd. stands at ₹ 24,234.60 Cr.
What is the PE ratio of Neuland Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Neuland Laboratories Ltd. is 66.58 as of the latest trailing twelve months data.
What is the ROE and ROCE of Neuland Laboratories Ltd.?
Neuland Laboratories Ltd. has a Return on Equity (ROE) of 21.42% and a Return on Capital Employed (ROCE) of 25.03% as per the latest financial reports.
What is the 52-week high and low of Neuland Laboratories Ltd.?
The 52-week high of Neuland Laboratories Ltd. is - and the 52-week low is -.
What is the dividend yield of Neuland Laboratories Ltd.?
The dividend yield of Neuland Laboratories Ltd. is 0.06% based on the current market price.
What is the FII and DII holding in Neuland Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 20.46%, Domestic Institutional Investors (DII) hold 12.65% and retail/public investors hold 26.22% of Neuland Laboratories Ltd. shares.
What sector does Neuland Laboratories Ltd. belong to?
Neuland Laboratories Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Neuland Laboratories Ltd. with a consensus target price of ₹ 20,712.50, implying 9.65% upside from current levels.
What is the beta of Neuland Laboratories Ltd.?
The beta of Neuland Laboratories Ltd. is 0.85, indicating its price volatility relative to the broader market. Over the past 1 year, Neuland Laboratories Ltd. has delivered an absolute return of 57.41%.
What is the RSI of Neuland Laboratories Ltd.?
The 14-day Relative Strength Index (RSI) of Neuland Laboratories Ltd. is 72.16, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.